Background activity of the amygdalin as antitumor

Abstract

Cancer is one of the most deadliest disease in the world nearly 10% of world population is suffering with the various types of the cancerous condition as a growth in the science now a day’s scientist has discovered various types of like chemotherapy, radiotherapy, immunotherapy and some other treatment, but in the mid of the 18th century an compound called amyglidn was identified as best treatment for cancer condition to many patients but in the starting of the 20th century it was thought to be not the safest treatment for the cancer so it was banned to use for the patients. Some scientist has scaled the positives and negatives of the amyglidn and concluded that more number of negatives than that of the positives. But there are few supporters for the treatment of the amyglidn to cancer patients.